Curriculum: Multidisciplinary tactics in the treatment of mPCa patients

This online curriculum addresses multidisciplinary tactics in the treatment of metastatic prostate cancer (mPCa) patients and is a mix of recorded interviews, live webinars, case discussions and podcasts by key opinion leaders in prostate cancer. The programme is developed by the European Association of Urology.

The objective of this curriculum is to provide easily accessible and engaging educational material in one place to enable urologists to be more holistic and better prepared to be members of multidisciplinary care teams. Topics covered will include:

EAUTV:  Programme highlights covering the Lancet Commission, new trials, data updates, and patient involvement in trials on advanced prostate cancer.

UROonco: 1-1 interviews covering quality of life (QoL), genomics and the role of urologists in the treatment of mPCa patients.

UROwebinar:   With a focus on strengthening the HCPs’ understanding of commonly faced adverse events and their early detection, improving toxicity management strategies through discussion and case studies, and promoting the importance of a multidisciplinary team (MDT) approach for coordinated care.

EMUC: mPCa – Difficult case management discussion from a multidisciplinary approach

This educational activity has been funded by Astra Zeneca. The educational programme of this online activity has been a collaboration with Astra Zeneca, but independently developed and approved by the European Association of Urology.